Harmonizing cancer control in Europe.
Harmonizing cancer control in Europe should be a win situation not only for the cancer patients, but also for the different cancer research organizations. With the common vision of European oncology it will be possible to formulate strategic goals. One of these goals is the establishment of comprehensive cancer centers, either cancer hospitals or coordinated comprehensive cancer centers. It is important to identify the necessary structures needed to increase the innovation potential, and this includes not only care and diagnostic technologies but also prevention. We need to establish a harmonized evaluation procedure. Positive outcome measurements are important to demonstrate the effects of research on the treatment of our patients. For optimal innovation the establishment of translational research environments at the cancer centers are mandatory. In order to avoid fragmentation both in care and research, European collaboration must increase.
Ringborg
Ulrik
U
Professor of Oncology, Karolinska Institute, Stockholm, Sweden.
D003695:Delivery of Health Care / Q000458:organization & administration*; D005060:Europe / Q000453:epidemiology; D006801:Humans; D007373:Interinstitutional Relations; D009369:Neoplasms / Q000401:mortality* / Q000517:prevention & control* / Q000628:therapy